BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32522235)

  • 1. Assessment of two POC technologies for CD4 count in Morocco.
    Elharti E; Abbadi H; Bensghir R; Marhoum El Filali K; Elmrabet H; Oumzil H
    AIDS Res Ther; 2020 Jun; 17(1):31. PubMed ID: 32522235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon.
    Sagnia B; Mbakop Ghomsi F; Gutierrez A; Sosso S; Kamgaing R; Nanfack AJ; Nji N; Ambada G; Lissom A; Tchouangueu TF; Ngu Ndengkoh L; Domkam I; Nchinda G; Ndjolo A
    AIDS Res Ther; 2020 Aug; 17(1):53. PubMed ID: 32799909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection.
    Makadzange AT; Bogezi C; Boyd K; Gumbo A; Mukura D; Matubu A; Ndhlovu CE
    PLoS One; 2016; 11(7):e0157546. PubMed ID: 27388763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
    Negedu-Momoh OR; Jegede FE; Yakubu A; Balogun O; Abdullahi M; Badru T; Oladele EA; Agbakwuru C; Khamofu H; Torpey K
    PLoS One; 2017; 12(5):e0178037. PubMed ID: 28542359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
    Galiwango RM; Lubyayi L; Musoke R; Kalibbala S; Buwembo M; Kasule J; Serwadda D; Gray RH; Reynolds SJ; Chang LW
    PLoS One; 2014; 9(3):e88928. PubMed ID: 24614083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BD FACSPresto Point of Care CD4 Test Accurately Enumerates CD4+ T Cell Counts.
    Bwana P; Vojnov L; Adhiambo M; Akinyi C; Mwende J; Prescott M; Mwau M
    PLoS One; 2015; 10(12):e0145586. PubMed ID: 26720601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the BD FACSPresto system for the measurement of CD4 T-lymphocytes and hemoglobin concentration in HIV-negative and HIV-positive subjects.
    Lu X; Sun H; Li H; Xia W; Wu H; Chen D; Tan M; Yu S; Zhang T; Sheng H; Zhu Z
    Sci Rep; 2020 Nov; 10(1):19605. PubMed ID: 33177659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya.
    Zeh C; Rose CE; Inzaule S; Desai MA; Otieno F; Humwa F; Akoth B; Omolo P; Chen RT; Kebede Y; Samandari T
    J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of FACSPresto Point-of-Care Instrument for CD4-T Cell Enumeration in Human Immunodeficiency Virus (HIV)-Infected Patients Attending Care and Treatment Clinics in Belgium and Tanzania.
    Daneau G; Aboud S; Prat I; Urassa W; Kestens L
    PLoS One; 2017; 12(1):e0170248. PubMed ID: 28129324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PIMA point-of-care CD4 analyzer in Yunnan, China.
    Liang J; Duan S; Ma YL; Wang JB; Su YZ; Zhang H; Ou CY; Hao L; Qi MS; Bulterys M; Westerman L; Jiang Y; Xiao Y
    Chin Med J (Engl); 2015 Apr; 128(7):890-5. PubMed ID: 25836608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the BD-FACS Presto for CD4 count and hemoglobin measurement in a district hospital and rural laboratory in Ghana.
    Moran Z; Sacks JA; Frimpong FK; Frimpong AB; Ben Amor Y
    PLoS One; 2019; 14(2):e0212684. PubMed ID: 30794637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.
    Myer L; Daskilewicz K; McIntyre J; Bekker LG
    J Int AIDS Soc; 2013 Sep; 16(1):18649. PubMed ID: 24044627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients.
    Wade D; Daneau G; Aboud S; Vercauteren GH; Urassa WS; Kestens L
    J Acquir Immune Defic Syndr; 2014 Aug; 66(5):e98-107. PubMed ID: 24853304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of PIMA analyzer detecting CD4 cell count of venous and capillary blood in HIV-infected individuals].
    Su YZ; Jia MH; Jiang Y; Xiao Y; Shi YH; Chen HC; Yan WY; Yang L; Yang CJ; Chen M; Dong LJ; Ma YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Nov; 47(11):1001-5. PubMed ID: 24507227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV Patients in the Interior of the Amazon Region, Brazil.
    Pinto IC; Sabidó M; Pereira AB; Mello MB; de Melo Xavier Shimizu A; Protti BL; Benzaken AS
    PLoS One; 2015; 10(4):e0121400. PubMed ID: 25905775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.
    Diaw PA; Daneau G; Coly AA; Ndiaye BP; Wade D; Camara M; Mboup S; Kestens L; Dieye TN
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):e103-11. PubMed ID: 21909029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.
    Sukapirom K; Onlamoon N; Thepthai C; Polsrila K; Tassaneetrithep B; Pattanapanyasat K
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):141-7. PubMed ID: 21709568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field Performance of PIMA Point-of-Care Machine for CD4 Enumeration Under a Mobile HIV Counseling and Testing Program in Remote Fishing Communities of Lake Victoria, Uganda.
    Namuniina A; Lutwama F; Biribawa VM; Kizza D; Kabuubi BR; Kitandwe PK; Mpendo J; Nanvubya A; Ssempiira J; Nalutaaya A; Ssetaala A; Welsh S; Price MA; Kiwanuka N; Bagaya BS
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):382-387. PubMed ID: 30560683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
    Mnyani CN; McIntyre JA; Myer L
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the performance of the Pima™ CD4 for point of care testing.
    Scott LE; Campbell J; Westerman L; Kestens L; Vojnov L; Kohastsu L; Nkengasong J; Peter T; Stevens W
    BMC Med; 2015 Jul; 13():168. PubMed ID: 26208867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.